Retinoic Acid Is a High Affinity Selective Ligand for the Peroxisome Proliferator-activated Receptor β/δ
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Retinoic acid (RA) modulates transcription of numerous target genes, thereby regulating a myriad of biological processes. It is well established that RA functions by activating retinoic acid receptors (RARs), which, in turn, control cell differentiation, proliferation, and apoptosis. However, perplexing reports of diverse and sometime opposing actions of RA have been published. Hence, while RA induces apoptosis and inhibits cell growth in some settings, it potentiates proliferation and acts as an anti-apoptotic agent in others. These observations raise the possibility that signaling pathways other than RAR may be involved in mediating RA activities. Here we show that RA is a high affinity ligand for another nuclear receptor, namely the orphan receptor peroxisome proliferator-activated receptor (PPAR) beta/delta. We demonstrate that while RA does not activate PPARalpha and PPARgamma, it binds to PPARbeta/delta with nanomolar affinity, modulates the conformation of the receptor, promotes interaction with the coactivator SRC-1, and efficiently activates PPARbeta/delta-mediated transcription. Transcriptional signaling by RA is thus exerted by a dual pathway, providing a rationale for understanding divergent cellular responses to this hormone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
Desvergne, B., & Wahli, W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0380 · Cited by 3,086
A decade of molecular biology of retinoic acid receptors
Chambon, P. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.9.8801176 · Cited by 2,889
Molecular recognition of fatty acids by peroxisome proliferator-activated receptors
Xu, H. E., Lambert, M. H., Montana, V. G., Parks, D. J., Blanchard, S. G., Brown, P. J., Sternbach, D. D., Lehmann, J. M., Wisely, G. B., Willson, T. M., et al. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80467-0 · Cited by 1,169
The Retinoids-Biology, Chemistry and Medicine
Wolf, G. (1994) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/60.5.796a · Cited by 998
A canonical structure for the ligand-binding domain of nuclear receptors
Wurtz, J.-M., Bourguet, W., Renaud, J.-P., Vivat, V., Chambon, P., Moras, D., & Gronemeyer, H. (1996) · Nature Structural Biology · doi:10.1038/nsb0196-87 · Cited by 985
Retinoids in Embryonal Development
Ross, S. A., McCaffery, P. J., Drager, U. C., & De Luca, L. M. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1021 · Cited by 866
Gampe, R. T., Montana, V. G., Lambert, M. H., Miller, A. B., Bledsoe, R. K., Milburn, M. V., Kliewer, S. A., Willson, T. M., & Xu, H. E. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80448-7 · Cited by 574
Breitman, T., Collins, S., & Keene, B. (1981) · Blood · doi:10.1182/blood.v57.6.1000.1000 · Cited by 571
Tan, N.-S., Shaw, N. S., Vinckenbosch, N., Liu, P., Yasmin, R., Desvergne, B., Wahli, W., & Noy, N. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.14.5114-5127.2002 · Cited by 499
Self-citationRetinoids in cancer chemoprevention
Lotan, R. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.9.8801164 · Cited by 423
Research works printed but not linked: 8
- Raffo, P., Emionite, L., Colucci, L., Belmondo, F., Moro, M. G., Bollag, W., and Toma, S. (2000) Anticancer Res. 20, 1535-1543
- Desvergne, B., and Wahli, W. (1999) Endocr. Rev. 20, 649 -688
- Seewaldt, V. L., Johnson, B. S., Parker, M. B., Collins, S. J., and Swisshelm, K. (1995) Cell Growth Differ. 6, 1077-1088
- Lee, H. Y., Dawson, M. I., Walsh, G. L., Nesbitt, J. C., Eckert, R. L., Fuchs, E., Hong, W. K., Lotan, R., and Kurie, J. M. (1996) Cell Growth Differ. 7, 997-1004
- Yen, A., Roberson, M. S., Varvayanis, S., and Lee, A. T. (1998) Cancer Res. 58, 3163-3172
- Wightman, J., Roberson, M. S., Lamkin, T. J., Varvayanis, S., and Yen, A. (2002) Mol. Cancer Ther. 1, 493-506
- Jinno, H., Steiner, M. G., Nason-Burchenal, K., Osborne, M. P., and Telang, N. T. (2002) Int. J. Oncol. 21, 127-134
- Sapi, E., Flick, M. B., Tartaro, K., Kim, S., Rakhlin, Y., Rodov, S., and Kacinski, B. M. (1999) Cancer Res. 59, 5578 -5585
Cited by
Items 201–244 of 244
Vitamin A Metabolism: Challenges and Perspectives
Ziouzenkova, O. (2012) · Vitamins & Minerals · doi:10.4172/2376-1318.1000e106 · Cited by 3
Shibuya, N., Nemoto, E., Kanaya, S., Kunii, R., & Shimauchi, H. (2005) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2005.00811.x · Cited by 3
Zeng, X., Yin, L., Zhang, Y., Wang, Q., Li, J., Yin, Y., Wang, Q., Li, J., & Yang, H. (2025) · Biological Trace Element Research · doi:10.1007/s12011-025-04546-9 · Cited by 2
“In addition, the retinol-retinoic acid metabolic pathway can activate the expression of the PPAR signaling pathway [53].”
Retinol-induced intestinal tumorigenesis in Min/+ mice and importance of vitamin D status.
Hetland, R. B., Alexander, J., Berg, J. P., Svendsen, C., & Paulsen, J. E. (2009) · PubMed · Cited by 4
Zhou, Y., Zhang, Q., Ding, R., Fan, X., Li, Q., & Li, Z. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123463 · Cited by 3
Yu, W., Tang, W., Lin, W. J., Jiang, L., Xiang, Y., Li, Y., Zhou, Y., Chen, Y., Zhao, W., Zhu, Y., et al. (2025) · Molecular Therapy Oncology · doi:10.1016/j.omton.2025.200992 · Cited by 3
Retinoids and the metabolic syndrome
O’Byrne, S. M., & Blaner, W. S. (2008) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.3.5.539 · Cited by 3
Tissue Distribution and Versatile Functions of PPARs
Youssef, J., & Badr, M. Z. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-420-3_5 · Cited by 5
Tung, Y., Lyu, K.-N., Chen, Y.-C., & Chien, Y. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.11.010 · Cited by 3
Holloway, J. W., & Wu, J. (2019) · Springer eBooks · doi:10.1007/978-981-13-7860-7_7 · Cited by 2
Retinoids: Molecular Aspects and Treatment in Premalignant Lesions and Cervical Cancer
Cortés-Malagón, E. M., Gariglio, P., Sierra-Martínez, M., & Bonilla‐Delgado, J. (2024) · Cancer Control · doi:10.1177/10732748241279514 · Cited by 2
The mechanisms underlying COVID-19 induced insulin resistance: a narrative review
Zhu, B., Qu, S., Li, J., Deng, W., Shen, W., & Chen, J. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1781679 · Cited by 2
Berbis, P. (2009) · EMC - Dermatología · doi:10.1016/s1761-2896(09)70343-7 · Cited by 1
Nuclear Hormone Receptor Medicinal Chemistry
Cheng, P. T. W., Kick, E. K., & Mukherjee, R. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc191 · Cited by 1
Delage, B. (2005) · Cited by 1
Serra, L. S. (2014) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Barroso, E., Serrano-Marco, L., Salvad, L., Palomer, X., & Vzquez-Carrer, M. (2012) · InTech eBooks · doi:10.5772/27647
“In addition, all-trans-retinoic acid (vitamin A) (Shaw et al., 2003) and fatty acids derived from VLDL (Chawla et al., 2003) can activate PPAR┚/├Finally, the availability of three synthetic ligands (GW501516, GW0742 and L-165041) that activate PPAR┚/├ at very low concentrations both in vivo and in…”
BackgroundUse of Retinoid Receptor Ligands to Identify Other Nuclear Receptor Ligands
Dawson, M. I., & Xia, Z. (2015) · doi:10.1002/9781118628003.ch10
The Dual Transcriptional Activity of Retinoic Acid
Noy, N. (2015) · Wiley eBooks · doi:10.1002/9781118628003.ch11 · Cited by 2
Self-citationVolakakis, N. (2010) · Figshare
DUAL TRANSCRIPTIONAL ACTIVITIES UNDERLIE OPPOSING EFFECTS OF RETINOIC ACID IN MAMMARY CARCINOMA
Thad, S. (2007) · eCommons (Cornell University)
Bianchi, A., Moulin, D., Terlain, B., & Netter, P. (2005) · Revue du Rhumatisme · doi:10.1016/j.rhum.2004.12.023
Bu, P. (2009) · KU ScholarWorks (University of Kansas)
Shionyu‐Mitsuyama, C., Waku, T., Shiraki, T., Oyama, T., Shirai, T., & Morikawa, K. (2011) · Protein Engineering Design and Selection · doi:10.1093/protein/gzq121
“Retinoic acid and eicosanoids (Krey et al., 1997; Shaw et al., 2003) have been identified as the endogenous ligands of these NRs (Forman et al., 1995).”
BackgroundEnergy Metabolism Regulates Retinoic Acid Synthesis and Homeostasis in Physiological Contexts
Obrochta, K. M. (2014) · eScholarship (California Digital Library)
Retinoic acid in adipocyte biology
Berry, D. C. (2011) · OhioLink ETD Center (Ohio Library and Information Network)
ReviewArticle The Role of PPARs in Cancer
Tachibana, K., Yamasaki, D., Ishimoto, K., & Doi, T. (2008)
Vreeland, A. C. (2015) · OhioLink ETD Center (Ohio Library and Information Network)
Sapiro, J. M. (2017) · UA Campus Repository (The University of Arizona)
The Interaction of Nutrition with Nuclear Receptors in Obesity and Diabetes
Tovar‐Palacio, C., Noriega, L. G., Torre-Villalvazo, I., Díaz‐Villaseñor, A., & Palacios‐González, B. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781839160608-00094
Youssef, J., & Badr, M. Z. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-420-3_4
Nuclear Hormone Receptor Medicinal Chemistry
Cheng, P. T. W., Kick, E. K., & Mukherjee, R. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc191.pub2
Dawson, M. I. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc065.pub2
Berbis, P. (2009) · EMC - Dermatologie · doi:10.1016/s0246-0319(09)48113-5 · Cited by 2
Clinical Relevance of DifferentialRARαandPPARβ/δExpression in Myelodysplastic Syndromes
Kalitin, N. N., Dudina, G. A., Kostritsa, N., Sivirinova, A., Vaiman, A. V., & Karamysheva, A. F. (2024) · In Vivo · doi:10.21873/invivo.13486
“Shaw et al. have demonstrated that ATRA was a specific ligand for PPARβ/δ, as well as for RARs, whereas PPARα and PPARγ were not activated by retinoic acid (21).”
BackgroundWang, C. (2010) · eScholarship (California Digital Library)
Hossain, M. N., & Du, . (2026) · Meat and Muscle Biology · doi:10.22175/mmb.20408
Evolution of the retinoic acid receptor
Gutierrez-Mazariegos, J. (2014) · theses.fr (ABES) · doi:10.70675/361e9701z45c1z4914z9bc7z9d25e1c92665 · Cited by 1
Retinoic acid signaling in chordates : the evolutionary history of a morphogen-dependent signaling
Carvalho, J. E. (2017) · theses.fr (ABES) · doi:10.70675/d7ca0d25zbfe5z46caz8d50zcd071004e022
Retinoid dynamics in immune cells during age-related diseases
Wang, Y., Muslihah, A. T., Fu, M., Dong, X., & Fu, Y. L. (2026) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2026.07.001
Yokoyama, Y., Osari, N., Taworntawat, T., Sekimoto, S., Tsubota, K., Kitamura, N., & 渡辺, 光. (2026) · Foods · doi:10.3390/foods15183209
“Potential factors promoting an increase in Ucp3 expression include non-esterified fatty acids [39,40], superoxide anion [39,40], thyroid hormone [41], 9-cis retinoic acid [42,43], leptin [41], and irisin [44].”
Efecte de l'activació de PPARβ/δ sobre l'oxidació d'àcids grassos i el procés inflamatori
Barroso, E. (2011) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Metadata
- Authors
- Shaw, N., Elholm, M., & Noy, N.
- Affiliations
- Cornell University (US)
- Corresponding author
- Noy, Noa
- ORCID
- Noy, Noa
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-10
- Volume
- 278
- Issue
- 43
- Pages
- 41589-41592
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2047682339
- Cited by
- 243
- References
- 39
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 7 · 2023: 7 · 2022: 1 · 2021: 9 · 2020: 11 · 2019: 14 · 2018: 7 · 2017: 9 · 2016: 15 · 2015: 13 · 2014: 12 · 2013: 21 · 2012: 13
- FWCI
- 2.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6206 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (DK060684)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- retinoic acid, PPARδ, peroxisome proliferator-activated receptors, nuclear receptor ligand binding, orphan nuclear receptor, retinoic acid receptor, PPARα, PPARγ, SRC-1 coactivator, receptor conformational change, transcriptional activation, apoptosis, cell proliferation
- MeSH terms
- Animals, Dose-Response Relationship, Drug, Ligands, Protein Binding, Protein Conformation, Transcription Factors, Transcription, Genetic, Transfection, Tretinoin, Signal Transduction, Titrimetry, Receptors, Cytoplasmic and Nuclear, COS Cells, Histone Acetyltransferases, Nuclear Receptor Coactivator 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.